Tag results:
CD8
Human Immunology News
Tumor Microenvironment and Its Clinicopathological and Prognostic Associations in Surgically Resected Cutaneous Angiosarcoma
[Clinical and Translational Oncology] Pretreated specimens were evaluated by immunohistochemistry for programmed cell death protein 1 and its ligand, densities of tumor infiltrative lymphocytes, as well as c-MYC and Ki-67 expressions.
Immune Regulation News
CXCR3 Regulates Stem and Proliferative CD8+ T Cells during Chronic Infection by Promoting Interactions with DCs in Splenic Bridging Channels
[Cell Reports] The authors observed distinct locations for parasite-specific T cell subsets, implying a link between differentiation and anatomical niches in the spleen.
Cell Therapy News
Magnesium Sensing via LFA-1 Regulates CD8+ T Cell Effector Function
[Cell] Low serum magnesium levels were associated with more rapid disease progression and shorter overall survival in CAR T cell and immune checkpoint antibody-treated patients.
Immunology of Infectious Disease News
Single-Cell Immune Profiling Reveals Functional Diversity of T Cells in Tuberculous Pleural Effusion
[Journal of Experimental Medicine] Using single-cell transcriptomics and T cell receptor sequencing, scientists analyzed mononuclear cell populations in paired pleural fluid and peripheral blood of tuberculous pleural effusion patients.
Immunology of Infectious Disease News
SARS-CoV-2 Vaccination Induces Immunological T Cell Memory Able to Cross-Recognize Variants from Alpha to Omicron
[Cell] In subjects ∼6 months post-vaccination, 90% and 87% of memory T cell responses were preserved against variants on average by AIM assay, and 84% and 85% preserved against Omicron.
Immunology of Infectious Disease News
Single-Cell Multi-Omics Reveals Dyssynchrony of the Innate and Adaptive Immune System in Progressive COVID-19
[Nature Communications] Investigators used multi-omics single-cell analysis to probe the dynamic immune responses in hospitalized patients with stable or progressive course of COVID-19, explore V(D)J repertoires, and assess the cellular effects of tocilizumab.